Stay updated on Pegilodecakin and FOLFOX in Pancreatic Cancer Clinical Trial
Sign up to get notified when there's something new on the Pegilodecakin and FOLFOX in Pancreatic Cancer Clinical Trial page.

Latest updates to the Pegilodecakin and FOLFOX in Pancreatic Cancer Clinical Trial page
- Check3 days agoChange DetectedRevision updated from v3.4.2 to v3.4.3 with no visible changes to study content.SummaryDifference0.0%

- Check11 days agoNo Change Detected
- Check18 days agoNo Change Detected
- Check32 days agoChange DetectedAdded Revision: v3.4.2 to the page. Deleted the funding/operating status notice and the older Revision: v3.4.1 reference from the page.SummaryDifference0.2%

- Check39 days agoChange DetectedThe page now displays a government funding lapse notice and NIH operating status update, and the site revision has been updated to v3.4.1 (replacing v3.4.0).SummaryDifference0.2%

- Check46 days agoChange DetectedAdded a Show glossary option and updated UI labels (including capitalization of QC metadata) with a revision bump from v3.3.4 to v3.4.0. These are minor editorial updates that do not change core study content or data.SummaryDifference0.1%

- Check60 days agoChange DetectedPage revision updated from v3.3.3 to v3.3.4. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check82 days agoChange Detected- Expanded and reorganized the Locations section to include a comprehensive list of study sites across multiple countries and U.S. states. - Previous grouped location headings were removed.SummaryDifference2%

Stay in the know with updates to Pegilodecakin and FOLFOX in Pancreatic Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pegilodecakin and FOLFOX in Pancreatic Cancer Clinical Trial page.